Zobrazeno 1 - 7
of 7
pro vyhledávání: '"William E Janssen"'
Autor:
Claudio Anasetti, Taiga Nishihori, Melissa Alsina, Heather S.L. Jim, L. Ochoa, William E. Janssen, Joseph Pidala, Teresa Field, Ernesto Ayala, Brian C. Betts, Lia Perez, Jongphil Kim, Marcie Tomblyn, Janelle Perkins, Frederick L. Locke, Hugo F. Fernandez, Anandaraman Veerapathran, Mian Xu, Mohamed A. Kharfan-Dabaja
Publikováno v:
Haematologica. 97(12)
Background: Evidence suggests activity of sirolimus in combination with tacrolimus in graft vs. host disease prevention. Sirolimus-based immune suppression may suppress alloreactive T cells, while sparing the survival and function of regulatory T cel
Autor:
Marcie Tomblyn, D. Rahn, D. Coyle, Claudio Anasetti, M. Hackett, R.C. Smilee, Hugo F. Fernandez, William E. Janssen
Publikováno v:
Bone marrow transplantation. 47(12)
Over the immediate past 4 years, our program has collected hematopoietic progenitor cells by apheresis from 48 individuals aged 61 and over (range 61-71 years of age). We have retrospectively analyzed the collection and transplant results associated
Autor:
Claudio Anasetti, D Hoda, Jose L. Ochoa-Bayona, John N. Greene, Joseph Pidala, Jongphil Kim, Mohamed A. Kharfan-Dabaja, William E. Janssen, N Salgado-Vila, Lia Perez, J. Raychaudhuri, Teresa Field, Ernesto Ayala, Melissa Alsina, Ryan Bookout, Janelle Perkins, Hugo F. Fernandez
Publikováno v:
Bone marrow transplantation. 45(8)
Acute GVHD (aGVHD) is a major cause of morbidity and mortality in hematopoietic allograft recipients. The best therapy for patients failing to respond, or not tolerating, systemic glucocorticoids remains undefined. We evaluated the efficacy of siroli
Autor:
Joseph Pidala, Brian C. Betts, Ernesto Ayala, Melissa Alsina, Marcie Tomblyn, Mian Xu, Mohamed A. Kharfan-Dabaja, Heather S.L. Jim, Leonel Ochoa, Janelle Perkins, Claudio Anasetti, William E. Janssen, Teresa Field, Taiga Nishihori, Lia Perez, Jongphil Kim, Hugo F. Fernandez, Frederick L. Locke
Publikováno v:
Blood. 118:323-323
Abstract 323 Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T cells (Treg) after Allogeneic Hematopoietic Cell Transplantation (HCT), and is More Effective than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft vs. H
Autor:
J. Leonel Ochoa-Bayona, Teresa Field, William E. Janssen, Claudio Anasetti, J. Raychaudhuri, Melissa Alsina, Jongphil Kim, John N. Greene, Mohamed A. Kharfan-Dabaja, Hugo F. Fernandez, Lia Perez, Daanish Hoda, Janelle Perkins, Joseph Pidala, Ernesto Ayala, Norma Salgado-Vila, Ryan Bookout
Publikováno v:
Blood. 114:2235-2235
Abstract 2235 Poster Board II-212 Acute graft-versus-host disease (aGVHD) remains the major cause of morbidity and mortality in allogeneic hematopoietic cell transplant recipients. There is no consensus in regards to the best therapy for patients who
Autor:
Phyllis I. Warkentin, Uger Coskun, William E. Janssen, James E. Talmadge, James R. Anderson, Dmitry I. Gabrilovich, James L. Wisecarver, Mary Mailliard, Sarah Maas, Orhan Turken, Kenneth H. Cowan, Elizabeth C. Reed
Publikováno v:
Blood. 112:4653-4653
Myeloid derived suppressor cells (MDSCs) have been reported to be expanded in cancer patients, following growth factor administration and after chemotherapy. These cells have been associated with a loss of T-cell number and function and provide one m
Autor:
William S. Dalton, Jyoti Raychaudhuri, Claudio Anasetii, Ernesto Ayala, Lia Perez, Dawn Kettner, Melissa Alsina, B. Maddox, Janelle Perkins, Daniel M. Sullivan, Mohamed A. Kharfan-Dabaja, Hugo F. Fernandez, Todd J. Alekshun, Christine Mcisaac-Simonelli, William E. Janssen, Dawn Garrett, Benjamin Djulbegovic, Teresa Field
Publikováno v:
Blood. 110:5131-5131
Background: Approximately 25% of patients with newly diagnosed (MM) fail to respond and progress while receiving conventional induction. As a result, these patients have primary refractory disease. Even though these patients still benefit from HD che